World's Best Scientists 2026 revealed!
María José Calasanz

María José Calasanz

D-Index & Metrics

Biology and Biochemistry

D-Index
71
Citations
19054
World Ranking
6606
National Ranking
107

María José Calasanz publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where María José Calasanz sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 459 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

María José Calasanz D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where María José Calasanz sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 71 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

María José Calasanz is affiliated with the University of Navarra in Spain and has made significant contributions to medical research, particularly in the field of hematology and molecular biology. Their work spans various areas within medicine, including cancer research and genetics.

Their recent publications highlight a focus on multiple myeloma and related hematological malignancies. Notable papers include:

  • Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma, 2020, Blood
  • Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma, 2022, Journal of Clinical Oncology
  • Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma, 2023, Nature Medicine
  • Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death, 2020, Cancer Discovery
  • Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma, 2020, Genome Research

Their research has been disseminated across several publication venues, frequently contributing to:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Cancers
  • HemaSphere
  • Leukemia

Coauthors with whom María José Calasanz has frequently collaborated include:

  • Joaquin Martínez-López
  • Jesús F. San Miguel
  • Bruno Paiva
  • María-Victoria Mateos
  • Pau Montesinos

The primary fields of study encompass medicine and biochemistry, genetics, and molecular biology, with subfields reflecting their detailed focus such as hematology, molecular biology, genetics, cancer research, and oncology.

  • Hematology
  • Molecular Biology
  • Genetics
  • Cancer Research
  • Oncology

The main topics that frame their research include:

  • Multiple Myeloma Research and Treatments
  • Acute Myeloid Leukemia Research
  • Protein Degradation and Inhibitors
  • Cancer Genomics and Diagnostics
  • Chronic Lymphocytic Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments

Best Publications

  • Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

    Mario F Fraga;Esteban Ballestar;Ana Villar-Garea;Manuel Boix-Chornet

  • Deregulated expression of cytokine receptor gene, CRLF2 , is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia

    Lisa J. Russell;Melania Capasso;Inga Vater;Takashi Akasaka

  • Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group

    Miguel A. Sanz;Guillermo Martín;Marcos González;Angel León

  • Landscape of somatic mutations and clonal evolution in mantle cell lymphoma

    Sílvia Beà;Rafael Valdés-Mas;Alba Navarro;Itziar Salaverria

  • Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia

    Xabier Agirre;Amaia Vilas-Zornoza;Antonio Jiménez-Velasco;José Ignacio Martin-Subero

  • Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.

    J Boultwood;J Perry;A Pellagatti;M Fernandez-Mercado

  • Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.

    José I Martín-Subero;Stefan Gesk;Lana Harder;Takashi Sonoki

  • Cytogenetic risk stratification in chronic myelomonocytic leukemia

    Esperanza Such;José Cervera;Dolors Costa;Francesc Solé

  • Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes

    Francesc Solé;Elisa Luño;Carmen Sanzo;Blanca Espinet

  • Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features

    Alba Navarro;Guillem Clot;Cristina Royo;Pedro Jares

  • Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.

    Xabier Agirre;Antonio Jiménez-Velasco;Edurne San José-Enériz;Leire Garate

  • Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia.

    Jose Roman-Gomez;Antonio Jimenez-Velasco;Juan A. Castillejo;Xabier Agirre

  • Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

    Panagiotis Baliakas;Sabine Jeromin;Michalis Iskas;Anna Puiggros

  • Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia

    José Román-Gómez;Lucia Cordeu;Xabier Agirre;Antonio Jiménez-Velasco

  • Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

    Takashi Akasaka;Theodore Balasas;Lisa J Russell;Kei-ji Sugimoto

  • Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations

    María J. Calasanz;Juan C. Cigudosa;María D. Odero;Carmen Ferreira

  • Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.

    Marta Salido;Cristina Baró;David Oscier;Kostas Stamatopoulos

  • Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy : long-term outcome of the LPA 99 multicenter study by the PETHEMA Group

    Miguel A. Sanz;Pau Montesinos;Edo Vellenga;Consuelo Rayón

  • Epigenetic Regulation of MicroRNAs in Acute Lymphoblastic Leukemia

    Jose Roman-Gomez;Xabier Agirre;Antonio Jiménez-Velasco;Victor Arqueros

  • SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia

    Ion Cristóbal;Francisco J. Blanco;Laura Garcia-Orti;Nerea Marcotegui

Frequent Co-Authors

Felipe Prosper
Felipe Prosper University of Navarra
Reiner Siebert
Reiner Siebert University of Ulm
Juan C. Cigudosa
Juan C. Cigudosa Instituto de Salud Carlos III
José I. Martín-Subero
José I. Martín-Subero University of Barcelona
Francesc Solé
Francesc Solé Autonomous University of Barcelona
Maria-Victoria Mateos
Maria-Victoria Mateos University of Salamanca
Miguel A. Sanz
Miguel A. Sanz University of Valencia
Marcos González
Marcos González University of Salamanca
Juan José Lahuerta
Juan José Lahuerta Complutense University of Madrid
Ramón García-Sanz
Ramón García-Sanz University of Salamanca

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in biology or biochemistry, you’ll find a wide range of complementary online degrees and career pathways in the U.S. Many students pursue advanced degrees such as an cheapest online mba healthcare to boost their medical or scientific careers with leadership and management skills.

For those who enjoy working with data and healthcare information, medical billing and coding are in-demand career options. Gaining a certification such as certified professional coder can open doors to specialized roles in hospitals and clinics. Many wonder about the earning potential in this field; the certified medical coder salary reflects steady demand and competitive compensation, especially with experience and further credentials.

It’s important to weigh the medical billing and coding outlook before making a decision. While these paths offer flexible, remote-friendly work options, they also require attention to detail and ongoing certification. Whether you’re interested in advanced degrees or specialized certifications, the U.S. offers plenty of online choices for biology and biochemistry enthusiasts ready to diversify their career journey.

Best Scientists Citing María José Calasanz

Trending Scientists

Recently Published Articles